The role of appendectomy in patients with mucinous borderline ovarian tumors

被引:9
|
作者
Song, Taejong [1 ]
Kim, Min Kyu [2 ]
Jung, Yong Wook [3 ]
Yun, Bo Seong [3 ]
Seong, Seok Ju [3 ]
Choi, Chel Hun [4 ]
Kim, Tae-Joong [4 ]
Lee, Jeong-Won [4 ]
Kim, Byoung-Gie [4 ]
Bae, Duk-Soo [4 ]
机构
[1] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Obstet & Gynecol, Sch Med, Seoul, South Korea
[2] Sungkyunkwan Univ, Samsung Changwon Hosp, Dept Obstet & Gynecol, Sch Med, Chang Won, South Korea
[3] CHA Univ, CHA Gangnam Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea
[4] Sungkyunkwan Univ, Samsung Med Ctr, Dept Obstet & Gynecol, Sch Med, 81 Irwon Ro, Seoul 06351, South Korea
关键词
Borderline ovarian tumors; Appendectomy; Appendix; Mutinous tumors; PSEUDOMYXOMA-PERITONEI; CLINICOPATHOLOGICAL ANALYSIS; ROUTINE APPENDECTOMY; NEOPLASMS; APPENDIX; ORIGIN; METAANALYSIS; PATHOLOGY; PROGNOSIS; SURGERY;
D O I
10.1016/j.ejogrb.2018.06.034
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: To determine the frequency of appendiceal involvement in patients undergoing surgery for mucinous borderline ovarian tumors (mBOTs), and to evaluate the associated morbidity, and the recurrence risk and survival after appendectomy. Study Design: The hospital databases were searched for women who underwent adnexal surgery at the Department of Obstetrics and Gynecology of four Korean academic hospitals, and whose final or frozen diagnosis was mBOTs. A literature search was performed, using electronic database (MEDLINE and EMBASE), to assess the available evidence on performing an appendectomy in patients with mBOTs. Results: Of the 473 included patients with mBOTs, 201 (42.5%) underwent appendectomy, 247 (52.2%) did not undergo appendectomy at the time of initial surgery, and 25 (5.3%) had previously undergone appendectomy. Among the 201 patients who underwent appendectomy, primary and metastatic appendiceal mucinous neoplasms were occurred in 1 patient each (0.5%), who showed a macroscopically abnormal appendix. Appendectomy itself was not associated with operative complications (P = 0.082), recurrence risk (P = 0.964), or survival (P = 0.219). Consistent with our findings, a comprehensive search of the literature revealed that the frequency of appendiceal involvement in mBOTs was less than 1% in either primary or metastatic appendiceal neoplasms. Conclusions: If the appendix is grossly normal, an appendectomy seems unnecessary in patients with mBOTs. However, a careful intra-operative exploration of the appendix is essential. (C) 2018 Published by Elsevier B.V.
引用
收藏
页码:112 / 116
页数:5
相关论文
共 50 条
  • [31] Clinicopathological Characteristics and Prognosis of 91 Patients with Seromucinous and Mucinous Borderline Ovarian Tumors: a Comparative Study
    Beibei Wu
    Jun Li
    Xiang Tao
    Jieyu Wang
    Guohua Zhu
    Xin Lu
    Ruifang Chen
    [J]. Reproductive Sciences, 2023, 30 : 1927 - 1937
  • [32] Clinicopathological Characteristics and Prognosis of 91 Patients with Seromucinous and Mucinous Borderline Ovarian Tumors: a Comparative Study
    Wu, Beibei
    Li, Jun
    Tao, Xiang
    Wang, Jieyu
    Zhu, Guohua
    Lu, Xin
    Chen, Ruifang
    [J]. REPRODUCTIVE SCIENCES, 2023, 30 (06) : 1927 - 1937
  • [33] ON DIFFERENTIAL-DIAGNOSIS OF BORDERLINE SEROUS AND MUCINOUS OVARIAN-TUMORS
    BOLKVADZE, MP
    GABUNIA, UA
    SHEININA, LI
    [J]. ARKHIV PATOLOGII, 1981, 43 (02) : 21 - 26
  • [34] Seromucinous and Mucinous Borderline Ovarian Tumors: We Need to Know More
    Mohamed Laban
    Xi Chen
    Bing Guo
    [J]. Reproductive Sciences, 2023, 30 : 1684 - 1685
  • [35] Seromucinous and Mucinous Borderline Ovarian Tumors: We Need to Know More
    Laban, Mohamed
    Chen, Xi
    Guo, Bing
    [J]. REPRODUCTIVE SCIENCES, 2023, 30 (05) : 1684 - 1685
  • [36] Endocervical Mucinous Borderline Ovarian Tumors: Immunohistochemical Profile and Clinical Correlations
    Zannoni, G. F.
    Petrillo, M.
    Santoro, M. L.
    Pesci, A.
    Rossi, E. D.
    Fadda, G.
    Castelli, P.
    Zamboni, G.
    Ceccaroni, M.
    Scambia, G.
    [J]. MODERN PATHOLOGY, 2014, 27 : 312A - 312A
  • [37] Endocervical Mucinous Borderline Ovarian Tumors: Immunohistochemical Profile and Clinical Correlations
    Zannoni, G. F.
    Petrillo, M.
    Santoro, M. L.
    Pesci, A.
    Rossi, E. D.
    Fadda, G.
    Castelli, P.
    Zamboni, G.
    Ceccaroni, M.
    Scambia, G.
    [J]. LABORATORY INVESTIGATION, 2014, 94 : 312A - 312A
  • [38] Prior appendectomy does not protect against subsequent development of malignant or borderline mucinous ovarian neoplasms
    Elias, Kevin M.
    Labidi-Galy, S. Intidhar
    Vitonis, Allison F.
    Hornick, Jason L.
    Doyle, Leona A.
    Hirsch, Michelle S.
    Cramer, Daniel W.
    Drapkin, Ronny
    [J]. GYNECOLOGIC ONCOLOGY, 2014, 132 (02) : 328 - 333
  • [39] Mullerian mucinous borderline tumors
    Rutgers, Joanne K. L.
    [J]. HUMAN PATHOLOGY, 2010, 41 (01) : 151 - 151
  • [40] Role of microsatellite instability in borderline ovarian tumors
    Casla, MS
    Lazaro, MV
    De Laral, IA
    Tresserra, F
    Marin, LL
    Maestro, M
    Dexeus, S
    [J]. ANTICANCER RESEARCH, 2003, 23 (6D) : 5139 - 5141